FDA Inspection 603192 — UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program

UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program — FEI 2074237

The FDA completed an inspection of UCLA Health, Component Processing Laboratory, Hematologic Malignancies/Stem Cell Transplantation Program on August 12, 2009 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 12, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Citations

IDCFRDescription
357021 CFR 211.100(a)Approval and review of procedures
9821 CFR 606.100(c)Thorough investigations